Analytic Investors’s Colgate-Palmolive CL Stock Holding History

Analytic Investors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$10.8M	Buy	145,376 +133,125	+1,087%	+$9.84M	0.12%	153
2016 Q2	$897K	Buy	+12,251	New	+$872K	0.01%	396
2014 Q3	–	Sell	-237,181	Closed	-$16.2M	–	608
2014 Q2	$16.2M	Buy	+237,181	New	+$15.9M	0.26%	99
2014 Q1	–	Sell	-341,267	Closed	-$22.3M	–	560
2013 Q4	$22.3M	Sell	341,267 -3,717	-1%	-$238K	0.37%	83
2013 Q3	$20.5M	Sell	344,984 -180,736	-34%	-$10.7M	0.33%	95
2013 Q2	$30.1M	Buy	+525,720	New	+$31.2M	0.5%	60

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Analytic Investors's CL Position: Q3 2016 in Review

Analytic Investors increased its Colgate-Palmolive (CL) stake by 1,087% in Q3 2016, buying an estimated $9.84M and bringing the position to 145,376 shares worth $10.8M. The position accounts for 0.12% of the portfolio, ranked #153.

Analytic Investors first reported a position in CL in Q2 2013 and has held it in 6 quarters since. The position peaked at $30.1M in Q2 2013. 1,300 funds tracked by Wall St. Rank hold CL as of Q3 2016.

Analytic Investors held 145,376 shares of Colgate-Palmolive worth $10.8M as of Q3 2016.
Analytic Investors bought 133,125 Colgate-Palmolive shares in Q3 2016, an estimated $9.84M.
Colgate-Palmolive made up 0.12% of Analytic Investors's portfolio in Q3 2016, its #153 holding.
Analytic Investors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 6 quarters since.
Analytic Investors's Colgate-Palmolive position peaked at $30.1M in Q2 2013.
1,300 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.